Startseite Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
Artikel Open Access

Growth suppression of glioma cells using HDAC6 inhibitor, tubacin

  • Changjiang Yin und Pibao Li EMAIL logo
Veröffentlicht/Copyright: 24. Mai 2018
Artikel downloaden (PDF)
Open Medicine
Aus der Zeitschrift Open Medicine Band 13 Heft 1

Abstract

In cancer research, autophagy has been revealed as one of the major ways to maintain the metabolism of cancer cells, including glioma cells, through protein degradation. Meanwhile, autophagy is also regarded as a kind of mechanism to protect glioma cells from a harmful stimulus, such as chemical and radiation treatment. So, the inhibition of autophagy may be very helpful in curing glioma. This study aimed to determine the effect of autophagic inhibition on glioma cells using tubacin, a specific inhibitor of histone deacetylase 6(HDAC6). According to the results, tubacin inhibited the growth of both U251 and LN229 cells, which was accompanied by lower HDAC6 activity and accumulated autophagosome. The inhibition of HDCA6 also led to accumulation of autophagosome and death of glioma cells. Moreover, the combined treatment of tubacin and temozolomide, an alkylating agent used to treat glioblastoma, induced more severe glioma cell death. Thus, it can be concluded that inhibition of HDAC6 suppressed growth and drug resistance of glioma cells in-vitro through autophagic suppression and blocking of fusion of autophagosome and lysosome.

Keywords: HDAC6; Glioma; Drug resistant; Autophage

1 Introduction

Among the primary central nervous system (CNS) tumors, 40% are glial neoplasms. According to the histopathological and clinical features identified by the World Health Organization (WHO), these neoplasms are classified into four grades [1]. High-grade gliomas, including glioblastoma multiforme (GBM) and anaplastic astrocytoma, threaten health most. Histological features of glioblastoma are marked by vascular proliferation, high cell density with mitotic activity and aggressive invasion into normal brain tissue [2]. Surgical resection followed by radiation and temozolomide treatment is the most frequent strategy used clinically to cure patients with glioma. However, radiation and temozolomide treatment can also induce protective autophagy to prevent excessive death of glioma cells [3].

Autophagy has been reported as one of the main path-ways for degradation of proteins, organelles and recycling materials in cells. This process is regulated by more than 30 autophagy-related proteins, such as Beclin1, ULK1, Atg5 and LC3B [4]. Responding to cellular stress, activated ULK1 and Beclin1 promote the initiation of autophagy, and then two ubiquitin-like (Atg12 and Atg8/LC3) conjugation systems mediate the autophagosome formation [5]. Finally, autophagosomes will fuse with lysosomes and degrade the contents engulfed in autophagosome [6]. Previous reports indicated that sustained autophagy could induce death of tumor cells [7,8]. Moreover, blocking fusion of autophagosome and lysosome by CQ could enhance the anti-cancer effect of nutrient deprivation [9]. Thus, inhibition of late autophagy may be a potential strategy to antagonize tumor.

Recent research has demonstrated that many histone deacetylase (HDAC) inhibitors like vorinostat and depsipetide participate in regulating the process of autophagy [10]. For example, HDAC6 has been reported to promote late autophagy. However, the mechanism of HDAC6-mediated autophagy is still unclear. Meanwhile, much less is known about the role of HDAC6 in glioma. In the current study, high HDAC6 expression in glioma tissue was detected, and it was found that tubacin, a specific small-molecule inhibitor of HDAC6, could suppress the growth and drug resistance of glioma cells invitro [11]. Moreover, it also demonstrated that tubacin suppressed late autophagyby influencing fusion of autophagosome and lysosome.

2 Materials and methods

2.1 Patients

The surgical specimens from 5 patients with glioma from 2015 to 2016 in our hospita’s department of neurosurgery were selected. Three specimens were collected from each case: tumor tissue, critical tissue and normal tissue, respectively. All tissues were frozen in liquid nitrogen tanks for later polymerase chain reaction (PCR) testing experiments. All of the cases had complete clinicopathological data. This study was approved by the hospital ethics committee and received the consent of the patients and their families.

2.2 Antibodies and reagents

Temozolomide, tubacin, Hoechst33342 and dimethyl sulfoxide (DMSO) were purchased from Sigma–Aldrich (St. Louis, MO, USA). Dulbecco’s modified Eagle’s medium (DMEM), antibiotics and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA, USA). Polyvinylidene difluoride (PVDF) membranes (Hybond-P) and enhanced chemiluminescence (ECL) kit were purchased from GE Healthcare Life Sciences (Piscataway, NJ, USA). Antibodies against acetyl- a-tubulin, a-tubulin, LC3B, p62/ SQSTM1, and HRP-conjugated sheep anti-rabbit IgG were all obtained from Cell Signaling Technology(Danvers, MA, USA). LAMP2 mouse monoclonal IgG was purchased from Santa Cruz.

2.3 Cell culture and immunoblotting

U251 and LN299 cells were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured in DMEM supplemented with 10% FBS (100 μg/ml) penicillin and 100 μg/ml streptomycin at 37oC in a humidified incubator with 5% CO2. U251 cells were seeded in 6-well plates for 24 hrs. Then cells were treated with or without tubacin. After indicated times, cells were washed thoroughly with ice-cold PBS and lysed with radioimmunoprecipitation assay (RIPA) buffer (Beyotime). Samples were then boiled and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) and transferred onto PVDF membranes. After incubation in blocking buffer (50 mM Tris-buffered saline (pH7.4) containing 5% non-fat milk and 0.1% Tween-20), the membranes were probed with indicated antibodies, followed by a horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG. Bands were revealed with the LumiGlo Chemiluminescent Substrate System (KPL).

2.4 Immunofluorescence staining

U251cells were fixed with 4% paraformaldehyde and permeabilized with 100% methanol. 10% normal goat serum was used to block the nonspecific binding with primary antibodies. Then cells were incubated with appropriate primary antibodies at 4oC overnight. After PBS wash, cells were incubated with CF568-conjugated goat-anti-mouse IgG or CF488-conjugated goat-anti-rabbit IgG (Biotium, Hayward, CA, USA) at room temperature for 1 hr. Nuclei were revealed by Hoechst33342 staining. Fluorescence images were collected under a Leica DMIRB fluorescent microscope (Leica Microsystems, Wetzlar, Germany) armed with a spinning disk confocal microscopy system (UltraView cooled CCD; Perkin Elmer, Waltham, MA, USA).

2.5 Cell proliferation assay

The same amount of U251 cells were seeded in 6-well plates in triplicate. After indicated times and treatment, cells were fixed with 10% methanol and stained with 0.1% crystal violet (dissolved in 10% methanol). After staining, wells were washed three times with PBS and de-stained with acetic acid. The absorbance of the crystal violet solution was measured at 590nm.

2.6 Real-time PCR

Total mRNA from tissues of patients with GBM was extracted using trizo®l (Invitrogen) while Omniscript RT Kit® (Qiagen) was used to produce cDNA. RT-PCR was performed using LC480 Real-Time PCR System (Roche) and SYBR Green PCR Master Mix (BioRad). Primers for qRT-PCR included HDAC6 sense (5’-AGTCTTATGGATGGCTATTGCATG-3’), HDAC6 antisense (5’-TGGACCAGTTAGAGGCCTTCAGG-3’). β-actin sense (5’-TCTACAATGAG-CTGCGT- GTG-3’), β-actinsense (5’-GGTCAGGATCTTCATGAGGT-3’).

2.7 Statistical analysis

Statistical analysis was performed with SPSS 10.0 software. Data were presented as mean ± standard deviation (SD). The difference between the two groups was evaluated by an un-paired t test. A value of p< 0.05 was considered as statistically significant.

3 Results

3.1 HDAC6 is highly expressed in tumor tissue of patients with GBM

To check the expression of HDAC6 in glioma tissue, the mRNA level of HDAC6 was detected by quantitive realtime PCR. The results showed that HDAC6 expression in tumor tissue from these patients was higher than in the control, whereas the average level of HDAC6 mRNA in tumor tissues was high compared with adjacent tissue of tumor from single patients as shown in Fig. 1A and B. In the samples from the same patients, the mRNA levels of HDAC6 in tumor tissues were also higher than in tissue adjacent to the tumor.

Figure 1 (a) HDAC6 mRNA in tissues from patients with GBM (b) HDAC6 mRNA in tumor tissues compared with adjacent tissue of tumor from single patients.The data shown in the figure was derived from 3 independent experiments. *P < 0.05, ***P < 0.001 versus normal tissue in panel A and versus adjacent tissue in panel B.
Figure 1

(a) HDAC6 mRNA in tissues from patients with GBM (b) HDAC6 mRNA in tumor tissues compared with adjacent tissue of tumor from single patients.The data shown in the figure was derived from 3 independent experiments. *P < 0.05, ***P < 0.001 versus normal tissue in panel A and versus adjacent tissue in panel B.

3.2 Tubacin growth inhibitory and temozolomide (TMZ) resistance effects on glioma cells

When treated with tubacin, the growth of U251 and LN299 cells was inhibited in a concentration-dependent way, as shown in Fig. 2A. Like chloroquine, tubacin also promotes accumulation of autophagosome, soit waspossible to determine whether tubacin can influence the TMZ resistance of glioma cells. As the results in Fig. 2B show, tubacin can reinforce TMZ toxicity on U251 cells and LN229 cells. Therefore, HDAC6 inhibition by tubacin can suppress the proliferation and TMZ resistance of glioma cells.

Figure 2 Tubacin inhibited the growth of glioma cells and enhanced the toxicity of temozolomide. (a) Human glioma cell lines LN229 and U251 were plated in 96-well plates (5×103/well) and cultured at 37°C for 24 hours. Then cells were treated with or without various concentrations of tubacin for 8 hours. Cell growth was monitored by crystal violet staining. (b) LN229 and U251 cells were plated in 96-well plates. After 24 hours, cells were treated with or without TMZ (200μM) in the presence or absence of tubacin (2nM) at 37°C for 8 hours. Cell viability was measured by crystal violet staining.
Figure 2

Tubacin inhibited the growth of glioma cells and enhanced the toxicity of temozolomide. (a) Human glioma cell lines LN229 and U251 were plated in 96-well plates (5×103/well) and cultured at 37°C for 24 hours. Then cells were treated with or without various concentrations of tubacin for 8 hours. Cell growth was monitored by crystal violet staining. (b) LN229 and U251 cells were plated in 96-well plates. After 24 hours, cells were treated with or without TMZ (200μM) in the presence or absence of tubacin (2nM) at 37°C for 8 hours. Cell viability was measured by crystal violet staining.

3.3 Autophagy suppression by HDAC6 inhibitor

We found that tubacin could inhibit the activity of HDAC6 and suppress autophagy. The lys-40 site of α-tubulin was the target of the catalytic activity of HDAC6 [12]. So, we used the acetylated level of lys-40 site in α-tubulin as the indicator of HDAC6 activity. The switch from LC3B-I to LC3B-II was considered as a marker of increased autophagic flux. After treatment with tubacin, the levels of LC3B-I and LC3B-II in U251 cells both increased, which meant a blockade of autophagic flux. Additionally, p62 has been reported as a marker for indicating the activity of late autophagy [13]. Tubacin treatment also induced p62 accumulation in U251 cells, which meant an impairment of autophagy as shown in Fig. 3A. Also, we found that tubacin treatment increased autophagosome formation, as shown in Fig. 3B. These results indicated that tubacin suppressed autophagy.

Figure 3 Inhibition of HDAC6 by tubacin suppressed autophagic degradation. (a) U251 cells were treated with the indicated concentration of tubacin. After 8 hours, cells were lysed and used for immunoblotting detection with antibodies. (b) U251 cells were plated and treated with CQ (25μM) or tubacin (2nM) for 8 hours. Then cells were fixed and used to detect autophagic puncta by immunofluorescence with LC3B antibodies. Scale bars, 10 μM..The data shown was derived from 3 independent experiments.*P < 0.05, **P < 0.01, ***P < 0.001 versus no tubacin group.
Figure 3

Inhibition of HDAC6 by tubacin suppressed autophagic degradation. (a) U251 cells were treated with the indicated concentration of tubacin. After 8 hours, cells were lysed and used for immunoblotting detection with antibodies. (b) U251 cells were plated and treated with CQ (25μM) or tubacin (2nM) for 8 hours. Then cells were fixed and used to detect autophagic puncta by immunofluorescence with LC3B antibodies. Scale bars, 10 μM..The data shown was derived from 3 independent experiments.*P < 0.05, **P < 0.01, ***P < 0.001 versus no tubacin group.

3.4 Blocking of fusion of autophagosome and lysosome by tubacin

To further investigate the mechanism by which tubacin suppresses autophagic degradation, we used double-staining immunofluorescence to detect the fusion of autophagosome and lysosome. LC3B antibody was used to label the autophagosome, and LAMP2 antibody was used to label the lysosome [14,15]. In our results, tubacin treatment strongly blocked the fusion of autophagosome and lysosome (Fig. 4A). According to the statistical analysis of the fused autolysosome in U251 cells, we found suppression of autophagosome and lysosome fusion (Fig. 4B). So, we concluded that tubacin suppressed late autophagy by blocking the formation of the autophagosome-lysosome complex.

Figure 4 Tubacin treatment blocked the fusion of autophagosome and lysosome. (a) U251 cells were treated with CQ (25μM) or tubacin (2nM) for 8 hours followed by immunofluorescence. Autophagosome was detected by LC3B antibody combined with CF488-conjugated goat-anti-rabbit antibody (green). Lysosome was detected by LAMP2 antibody combined with CF568-conjugated goat-anti-mouse antibody (rabbit). Scale bars, 10 μM. (b) Fused puncta, which indicated fused autolysosome, in 30 cells were obtained for statistical analysis.
Figure 4

Tubacin treatment blocked the fusion of autophagosome and lysosome. (a) U251 cells were treated with CQ (25μM) or tubacin (2nM) for 8 hours followed by immunofluorescence. Autophagosome was detected by LC3B antibody combined with CF488-conjugated goat-anti-rabbit antibody (green). Lysosome was detected by LAMP2 antibody combined with CF568-conjugated goat-anti-mouse antibody (rabbit). Scale bars, 10 μM. (b) Fused puncta, which indicated fused autolysosome, in 30 cells were obtained for statistical analysis.

4 Discussion

Currently, most therapeutic strategies used to cure tumor focus on apoptosis of tumor cells. However, apoptosis evasion is one of the major hallmarks of various types of cancer, including glioblastoma [16]. So, it is necessary to develop new methods that target non-apoptotic death pathways. Previously, there was some controversy about the role of autophagy in cancer. Some researchers thought the process of autophagy was a kind of protective pathway to antagonize stress or nutrition deficiency [17]. However, drugs that cannot induce apoptosis also promotecell death in many GBM cell lines. This may due to disposal of organelles by autophagic degradation and accumulation of autophagosome [18].

In this study, we examined the role of HDAC6 in the autophagy process and found that HDAC6 contributed to tumor development. Many small molecules are used to inhibit autophagy, such as chloroquine, 3-MA or LY294002. But the main challenge in current research on autophagy is the lack of specific inhibitors targeting the autophagic process. Previously, we found that tubacin, a specific small-molecule inhibitor of HDAC6, could inhibit the activity of HDAC6 and suppress autophagy.In autophagy, cargos are recognized by an autophagic cargo receptor, such as p62. Then these cargos are transferred to an autophagosome. Finally, the autophagosome fuses with lysosome and degrades the contents, with the help of proteolysis enzymes in lysosome.Like chloroquine, HDAC6 inhibitor-induced accumulation of autophagosome has been considered one of the main factors that causes autophagic cell death [9]. But, unlike chloroquine, HDAC6 inhibitor does not influence the formation of lysosome.

In our study, tubacin inhibited the growth of glioma cells and enhanced the toxicity of temozolomide in human glioma cell lines LN229 and U251 when treated with tubacin for 8 hours, which means HDAC6 inhibition by tubacin can suppress the proliferation and TMZ resistance of glioma cells.

HDAC6 is a special enzyme in the histone deacetylase family. Unlike other histone deacetylase, HDAC6 does not interact with histones. Besides deacetylating a-tubulin, HDAC6 also deacetylates cortactin, Hsp90. Moreover, HDAC6 is involved in many processes that are linked to cancer, including cell survival, motility, and metastasis, which makes it an attractive therapeutic target [19]. In our results, HDAC6 was highly expressed in GBM tumors compared with normal brain tissue, indicating that HDAC6 might promote tumor progression in GBMs. In summary, inhibition of HDAC6 is a potential choice to suppress growth and drug resistance of glioma. In conclusion, inhibition of HDAC6 can suppress both growth and drug resistance of glioma cells in vitro through autophagy suppression and blocking of fusion of autophagosome and lysosome.

Study limitations

In this article, we mainly compared the tumor tissue, the critical (scar) tissue and the normal tissue samples of the patients and carried out the related cell experiments. In this study, the number of patients was somewhat small, and statistical deviation was prone to occur. In addition, we did not use the expression of HDC6 gene in our experiment to observe its effect on the growth of tumor cells. Therefore, it is necessary to increase the number of samples of tumor tissue in the future, use the over-expression experiment and study the related mechanism.

Acknowledgments

No

  1. Grant support: Our research is not funded by any fund project

  2. Conflicts of interest: The authors have no conflicts of interest to declare.

References

[1] Friedman HS, Kerby T, Calvert H, Temozolomide and treatment of malignant glioma, Clin Cancer Res 6, 2000, 2585-2597Suche in Google Scholar

[2] Louis DN, Ohgaki H OD. Wiestler WK. Cavenee PC. Burger A. Jouvet BW. ScheithauerR, Kleihues P, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol 114, 2007, 97-10910.1007/s00401-007-0243-4Suche in Google Scholar PubMed PubMed Central

[3] Kaza NL. KohliKA. Roth RG, Autophagy in brain tumors: a new target for therapeutic intervention, Brain Pathol 22, 201210.1111/j.1750-3639.2011.00544.xSuche in Google Scholar PubMed PubMed Central

[4] Shibutani ST, Saitoh T, Nowag H, Münz C, Yoshimori T.Autophagy and autophagy-related proteins in the immune system.Nat Immunol. 2015 Oct;16(10):1014-102410.1038/ni.3273Suche in Google Scholar PubMed

[5] Tanida I.Autophagy basics.Microbiol Immunol. 2011 Jan;55(1):1-1110.1111/j.1348-0421.2010.00271.xSuche in Google Scholar PubMed

[6] Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy, Nature Reviews Clinical Oncology 8, 2011, 528-53910.1038/nrclinonc.2011.71Suche in Google Scholar PubMed

[7] Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy, Cancer Cell 14, 2008, 90-10210.1016/j.ccr.2008.06.004Suche in Google Scholar PubMed PubMed Central

[8] Geng Y, Kohli L, Klocke BJ, Roth KA, Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent, Neuro Oncol 12, 2010, 473-481Suche in Google Scholar

[9] Harhaji-Trajkovic L, Arsikin K, Kravic-Stevovic T, Petricevic TS, Tovilovic G, Pantovic A, Zogovic N, Ristic B, Janjetovic K, Bumbasirevic V, Trajkovic V, Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation, Pharm Res 29, 2012, 2249-226310.1007/s11095-012-0753-1Suche in Google Scholar PubMed

[10] McEwan DG, Dikic I, The Three Musketeers of Autophagy: phosphorylation, ubiquitylation and acetylation, Trends Cell Biol 21, 2011, 195-20110.1016/j.tcb.2010.12.006Suche in Google Scholar PubMed PubMed Central

[11] Husain M, Cheung CY, Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.J Virol. 2014 Oct;88(19):11229-1123910.1128/JVI.00727-14Suche in Google Scholar PubMed PubMed Central

[12] Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schlüter OM, Bradke F, Lu J, Fischer A.Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer’s disease. EMBO Mol Med. 2013 Jan;5(1):52-6310.1002/emmm.201201923Suche in Google Scholar PubMed PubMed Central

[13] Lee JK, Shin JH, Lee JE, Choi EJ.Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis.Biochim Biophys Acta. 2015 Nov;1852(11):2517-252410.1016/j.bbadis.2015.08.005Suche in Google Scholar

[14] Kerr RP, Krunkosky TM, Hurley DJ, Cummings BS, Holladay SD, Gogal RM Jr.Lead at 2.5 and 5.0 μM induced aberrant MH-II surface expression through increased MII exocytosis and increased autophagosome formation in Raw 267.4 cells. Toxicol In Vitro. 2013 Apr;27(3):1018-102410.1016/j.tiv.2013.01.018Suche in Google Scholar

[15] Agrawal V, Jaiswal MK, Mallers T, Katara GK, Gilman-Sachs A, Beaman KD, Hirsch E.Altered autophagic flux enhances inflammatory responses during inflammation-induced preterm labor.Sci Rep. 2015 Mar 23;5:941010.1038/srep09410Suche in Google Scholar

[16] Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy, Cell 108, 2002, 153-16410.1016/S0092-8674(02)00625-6Suche in Google Scholar

[17] Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy, Nature Reviews Cancer 5, 2005, 726-73410.1038/nrc1692Suche in Google Scholar PubMed

[18] Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, LaharanneE, Veron E, Vital NA, Loiseau H, Merlio PJ, Belloc F. Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death, Cancer Biology & Therapy 11, 2011, 1017-102710.4161/cbt.11.12.15693Suche in Google Scholar PubMed

[19] Aldana-Masangkay GI, Sakamoto KM, The Role of HDAC6 in Cancer, Journal Of Biomedicine And Biotechnology, 201110.1155/2011/875824Suche in Google Scholar PubMed PubMed Central

Received: 2018-01-01
Accepted: 2018-02-25
Published Online: 2018-05-24

© 2018 Changjiang Yin, Pibao Li et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. Cleidocranial dysplasia-dental disorder treatment and audiology diagnosis
  3. A hybrid neural network – world cup optimization algorithm for melanoma detection
  4. Early administration of venovenous extracorporeal life support for status asthmaticus during anaesthetic induction: case report and literature review
  5. Assessment of maximal isometric hand grip strength in school-aged children
  6. Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
  7. Value of continuous video EEG and EEG responses to thermesthesia stimulation in prognosis evaluation of comatose patients after cardiopulmonary resuscitation
  8. Platelet-rich plasma protects HUVECs against oX-LDL-induced injury
  9. Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China
  10. Small-cell lung cancer presenting as fatal pulmonary hemorrhage
  11. Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
  12. Prognosis of treatment outcomes by cognitive and physical scales
  13. The efficacy of radiofrequency hyperthermia combined with chemotherapy in the treatment of advanced ovarian cancer
  14. Arcuate Fasciculus in Autism Spectrum Disorder Toddlers with Language Regression
  15. Aesthetic dental procedures: legal and medico-legal implications
  16. Blood transfusion in children: the refusal of Jehovah’s Witness parents’
  17. Burnout among anesthetists and intensive care physicians
  18. Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis
  19. Ethical and legal issues in gestational surrogacy
  20. Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
  21. Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
  22. Pituitary dysfunction from an unruptured ophthalmic internal carotid artery aneurysm with improved 2-year follow-up results: A case report
  23. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
  24. Piercing and tattoos in adolescents: legal and medico-legal implications
  25. The central importance of information in cosmetic surgery and treatments
  26. Penile calciphylaxis in a patient with end-stage renal disease: a case report and review of the literature
  27. Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
  28. Association between uric acid and metabolic syndrome in elderly women
  29. Distinct expression and prognostic value of MS4A in gastric cancer
  30. MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
  31. Association of central obesity with sex hormonebinding globulin: a cross-sectional study of 1166 Chinese men
  32. Successful endovascular therapy in an elderly patient with severe hemorrhage caused by traumatic injury
  33. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
  34. Related factors of early mortality in young adults with cerebral hemorrhage
  35. Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
  36. Post-stroke upper limb spasticity incidence for different cerebral infarction site
  37. The esophageal manometry with gas-perfused catheters
  38. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
  39. Genetic testing: ethical aspects
  40. Intervention for physician burnout: A systematic review
  41. The melanin-concentrating hormone system in human, rodent and avian brain
  42. Clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease: A meta-analysis
  43. Identification of a novel BRAF Thr599dup mutation in lung adenocarcinoma
  44. Adrenal incidentaloma – diagnostic and treating problem – own experience
  45. Common illnesses in tropical Asia and significance of medical volunteering
  46. Genetic risk in insurance field
  47. Genetic testing and professional responsibility: the italian experience
  48. The mechanism of mitral regurgitant jets identified by 3-dimensional transesophageal echocardiography
  49. Control of blood pressure and cardiovascular outcomes in type 2 diabetes
  50. Pseudomesotheliomatous primary squamous cell lung carcinoma: The first case reported in Turkey and a review of the literature
  51. Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
  52. GPER was associated with hypertension in post-menopausal women
  53. Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  54. Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria
  55. The efficacy and safety of enoxaparin: a meta-analysis
  56. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis
  57. Thresholding for medical image segmentation for cancer using fuzzy entropy with level set algorithm
  58. Sleep deprivation in Intensive Care Unit – systematic review
  59. Benefits of computed tomography in reducing mortality in emergency medicine
  60. Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
  61. Limits of professional competency in nurses working in Nicu
  62. MDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
  63. The effect of smoking on posttraumatic pseudoarthrosis healing after internal stabilization, treated with platelet rich plasma (PRP)
  64. Partial deletion of the long arm of chromosome 7: a case report
  65. Meta-analysis of PET/CT detect lymph nodes metastases of cervical cancer
  66. High Expression of NLRC5 is associated with prognosis of gastric cancer
  67. Is monitoring mean platelet volume necessary in breast cancer patients?
  68. Resectable single hepatic epithelioid hemangioendothelioma in the left lobe of the liver: a case report
  69. Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
  70. The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
  71. Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
  72. Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions
  73. Analysis of patient satisfaction with emergency medical services
  74. Guillain-Barré syndrome and Low back pain: two cases and literature review
  75. HELLP syndrome complicated by pulmonary edema: a case report
  76. Pharmacokinetics of vancomycin in patients with different renal function levels
  77. Recurrent chronic subdural hematoma: Report of 13 cases
  78. Is awareness enough to bring patients to colorectal screening?
  79. Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
  80. Plastic treatment for giant pseudocyst after incisional hernia mesh repair: a case report and comprehensive literature review
  81. High expression levels of fascin-1 protein in human gliomas and its clinical relevance
  82. Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
  83. The effects of gastrointestinal function on the incidence of ventilator-associated pneumonia in critically ill patients
  84. A report of chronic intestinal pseudo-obstruction related to systemic lupus erythematosus
  85. Risk model in women with ovarian cancer without mutations
  86. Direct oral anticoagulants and travel-related venous thromboembolism
  87. How bispectral index compares to spectral entropy of the EEG and A-line ARX index in the same patient
  88. Henoch-schonlein purpura nephritis with renal interstitial lesions
  89. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
  90. CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
  91. Combination of novoseven and feiba in hemophiliac patients with inhibitors
https://doi.org/10.1515/med-2018-0034
Schlagwörter für diesen Artikel
HDAC6; Glioma; Drug resistant; Autophage
Creative Commons
BY-NC-ND 4.0

Artikel in diesem Heft

  1. Regular Articles
  2. Cleidocranial dysplasia-dental disorder treatment and audiology diagnosis
  3. A hybrid neural network – world cup optimization algorithm for melanoma detection
  4. Early administration of venovenous extracorporeal life support for status asthmaticus during anaesthetic induction: case report and literature review
  5. Assessment of maximal isometric hand grip strength in school-aged children
  6. Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
  7. Value of continuous video EEG and EEG responses to thermesthesia stimulation in prognosis evaluation of comatose patients after cardiopulmonary resuscitation
  8. Platelet-rich plasma protects HUVECs against oX-LDL-induced injury
  9. Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China
  10. Small-cell lung cancer presenting as fatal pulmonary hemorrhage
  11. Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
  12. Prognosis of treatment outcomes by cognitive and physical scales
  13. The efficacy of radiofrequency hyperthermia combined with chemotherapy in the treatment of advanced ovarian cancer
  14. Arcuate Fasciculus in Autism Spectrum Disorder Toddlers with Language Regression
  15. Aesthetic dental procedures: legal and medico-legal implications
  16. Blood transfusion in children: the refusal of Jehovah’s Witness parents’
  17. Burnout among anesthetists and intensive care physicians
  18. Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis
  19. Ethical and legal issues in gestational surrogacy
  20. Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
  21. Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
  22. Pituitary dysfunction from an unruptured ophthalmic internal carotid artery aneurysm with improved 2-year follow-up results: A case report
  23. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
  24. Piercing and tattoos in adolescents: legal and medico-legal implications
  25. The central importance of information in cosmetic surgery and treatments
  26. Penile calciphylaxis in a patient with end-stage renal disease: a case report and review of the literature
  27. Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
  28. Association between uric acid and metabolic syndrome in elderly women
  29. Distinct expression and prognostic value of MS4A in gastric cancer
  30. MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
  31. Association of central obesity with sex hormonebinding globulin: a cross-sectional study of 1166 Chinese men
  32. Successful endovascular therapy in an elderly patient with severe hemorrhage caused by traumatic injury
  33. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
  34. Related factors of early mortality in young adults with cerebral hemorrhage
  35. Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
  36. Post-stroke upper limb spasticity incidence for different cerebral infarction site
  37. The esophageal manometry with gas-perfused catheters
  38. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
  39. Genetic testing: ethical aspects
  40. Intervention for physician burnout: A systematic review
  41. The melanin-concentrating hormone system in human, rodent and avian brain
  42. Clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease: A meta-analysis
  43. Identification of a novel BRAF Thr599dup mutation in lung adenocarcinoma
  44. Adrenal incidentaloma – diagnostic and treating problem – own experience
  45. Common illnesses in tropical Asia and significance of medical volunteering
  46. Genetic risk in insurance field
  47. Genetic testing and professional responsibility: the italian experience
  48. The mechanism of mitral regurgitant jets identified by 3-dimensional transesophageal echocardiography
  49. Control of blood pressure and cardiovascular outcomes in type 2 diabetes
  50. Pseudomesotheliomatous primary squamous cell lung carcinoma: The first case reported in Turkey and a review of the literature
  51. Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
  52. GPER was associated with hypertension in post-menopausal women
  53. Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  54. Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria
  55. The efficacy and safety of enoxaparin: a meta-analysis
  56. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis
  57. Thresholding for medical image segmentation for cancer using fuzzy entropy with level set algorithm
  58. Sleep deprivation in Intensive Care Unit – systematic review
  59. Benefits of computed tomography in reducing mortality in emergency medicine
  60. Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
  61. Limits of professional competency in nurses working in Nicu
  62. MDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
  63. The effect of smoking on posttraumatic pseudoarthrosis healing after internal stabilization, treated with platelet rich plasma (PRP)
  64. Partial deletion of the long arm of chromosome 7: a case report
  65. Meta-analysis of PET/CT detect lymph nodes metastases of cervical cancer
  66. High Expression of NLRC5 is associated with prognosis of gastric cancer
  67. Is monitoring mean platelet volume necessary in breast cancer patients?
  68. Resectable single hepatic epithelioid hemangioendothelioma in the left lobe of the liver: a case report
  69. Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
  70. The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
  71. Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
  72. Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions
  73. Analysis of patient satisfaction with emergency medical services
  74. Guillain-Barré syndrome and Low back pain: two cases and literature review
  75. HELLP syndrome complicated by pulmonary edema: a case report
  76. Pharmacokinetics of vancomycin in patients with different renal function levels
  77. Recurrent chronic subdural hematoma: Report of 13 cases
  78. Is awareness enough to bring patients to colorectal screening?
  79. Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
  80. Plastic treatment for giant pseudocyst after incisional hernia mesh repair: a case report and comprehensive literature review
  81. High expression levels of fascin-1 protein in human gliomas and its clinical relevance
  82. Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
  83. The effects of gastrointestinal function on the incidence of ventilator-associated pneumonia in critically ill patients
  84. A report of chronic intestinal pseudo-obstruction related to systemic lupus erythematosus
  85. Risk model in women with ovarian cancer without mutations
  86. Direct oral anticoagulants and travel-related venous thromboembolism
  87. How bispectral index compares to spectral entropy of the EEG and A-line ARX index in the same patient
  88. Henoch-schonlein purpura nephritis with renal interstitial lesions
  89. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
  90. CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
  91. Combination of novoseven and feiba in hemophiliac patients with inhibitors
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 5.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2018-0034/html
Button zum nach oben scrollen